Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7100838 | 1.00 | MEN1 (0.37) | MEN1KMT2ACSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL5898756 | 0.83 | RAB9A (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL5898754 | 0.83 | RAB9A (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL1698508 | 0.79 | PIK3CD (0.35) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10959845 | 0.68 | LMNA (0.51) | MEN1KMT2ACSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL951298 | 0.68 | LMNA (0.51) | MEN1KMT2ACSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL2939484 | 0.68 | — | — | |
| SCHEMBL15773132 | 0.67 | LMNA (0.32) | CHRM2CHRM4CHRM1CHRM3LMNA | |
| SCHEMBL3728882 | 0.67 | LMNA (0.46) | MEN1KMT2ACSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL1698565 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030232820-A1 | Method for synthesizing oxazinones | WOLFE SAUL (CA) | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232820-A1 | Method for synthesizing oxazinones | DHPS, HSD17B12, PNPO | MEN1 2954/4885KMT2A 3995/4885CSNK2A2 1801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.